Search

everythinglearnresearchcommunity

for

Search:↓

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Cyclosporin A promotes hair cell growth and affects protein kinase C levels.

Objective assessment is needed to accurately determine medication use and adherence.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Thymectomy and high-dose prednisolone improved hair loss in a woman with alopecia areata.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.